A detailed history of Victory Capital Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 437,750 shares of RVMD stock, worth $24.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
437,750
Previous 542,601 19.32%
Holding current value
$24.7 Million
Previous $21.1 Million 5.81%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$36.92 - $47.94 $3.87 Million - $5.03 Million
-104,851 Reduced 19.32%
437,750 $19.8 Million
Q2 2024

Aug 05, 2024

SELL
$30.14 - $40.68 $1.75 Million - $2.36 Million
-57,980 Reduced 9.65%
542,601 $21.1 Million
Q1 2024

May 03, 2024

BUY
$26.56 - $33.55 $1.12 Million - $1.42 Million
42,212 Added 7.56%
600,581 $19.4 Million
Q4 2023

Feb 05, 2024

BUY
$18.35 - $34.12 $3.96 Million - $7.37 Million
216,010 Added 63.09%
558,369 $16 Million
Q3 2023

Nov 06, 2023

BUY
$25.17 - $35.05 $6.87 Million - $9.56 Million
272,848 Added 392.52%
342,359 $9.48 Million
Q2 2023

Jul 27, 2023

BUY
$20.28 - $27.0 $488,768 - $650,727
24,101 Added 53.07%
69,511 $1.86 Million
Q1 2023

May 02, 2023

SELL
$20.76 - $30.09 $59,373 - $86,057
-2,860 Reduced 5.93%
45,410 $983,000
Q4 2022

Feb 09, 2023

BUY
$17.68 - $25.53 $407,877 - $588,977
23,070 Added 91.55%
48,270 $1.15 Million
Q3 2022

Nov 02, 2022

BUY
$17.46 - $26.0 $439,992 - $655,200
25,200 New
25,200 $497,000
Q4 2021

Feb 07, 2022

SELL
$24.35 - $33.7 $180,092 - $249,245
-7,396 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$23.95 - $33.41 $8,550 - $11,927
-357 Reduced 4.6%
7,396 $203,000
Q2 2021

Aug 03, 2021

SELL
$29.0 - $47.44 $21.7 Million - $35.5 Million
-748,111 Reduced 98.97%
7,753 $246,000
Q1 2021

May 04, 2021

BUY
$37.21 - $54.43 $26.3 Million - $38.5 Million
707,459 Added 1461.54%
755,864 $34.7 Million
Q4 2020

Feb 01, 2021

SELL
$30.19 - $45.49 $228,779 - $344,723
-7,578 Reduced 13.54%
48,405 $1.92 Million
Q3 2020

Nov 09, 2020

BUY
$22.61 - $34.8 $827,367 - $1.27 Million
36,593 Added 188.72%
55,983 $1.95 Million
Q2 2020

Aug 07, 2020

SELL
$19.65 - $39.34 $868,903 - $1.74 Million
-44,219 Reduced 69.52%
19,390 $612,000
Q1 2020

May 04, 2020

BUY
$20.0 - $34.08 $1.27 Million - $2.17 Million
63,609 New
63,609 $1.39 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.